Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-23T12:51:56.088Z Has data issue: false hasContentIssue false
  • English
  • Français

Design and Methodology of the Strategies to Reduce Transmission of Antimicrobial Resistant Bacteria in Intensive Care Units (STAR-ICU) Trial

Published online by Cambridge University Press:  02 January 2015

W. Charles Huskins ,
Naomi P. O'Grady ,
Matthew Samore ,
Dennis Wallace ,
Donald A. Goldmann  and
Peter G. Pappas
W. Charles Huskins*
Affiliation:
Mayo Clinic College of Medicine, Rochester, Minnesota
Naomi P. O'Grady
Affiliation:
National Institutes of Health Clinical Center, Bethesda, Maryland
Matthew Samore
Affiliation:
University of Utah, Salt Lake City
Dennis Wallace
Affiliation:
Rho Federal Systems Division, Chapel Hill, North Carolina
Donald A. Goldmann
Affiliation:
Harvard Medical School, Boston, Massachusetts
Peter G. Pappas
Affiliation:
University of Alabama at Birmingham, Birmingham
*
Mayo Clinic, 200 First Avenue SW, Rochester, MN 55905 (huskins.charles@mayo.edu)
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Information
Infection Control & Hospital Epidemiology , Volume 28 , Issue 2 , February 2007 , pp. 245 - 246
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2007

References

1.Farr, BM. What to think if the results of the National Institutes of Health randomized trial of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus control measures are negative (and other advice to young epidemiologists): a review and an au revoir. Infect Control Hosp Epidemiol 2006;27:1096–1106.Google Scholar
2.ClinicalTrials.gov. Strategies to reduce transmission of antibiotic-resistant bacteria in intensive care units. Available at: http://www.clinicaltrials.gov/ct/show/NCT00342745?order = 8. Accessed October 9, 2006.Google Scholar
3.Muto, CA, Jernigan, JA, Ostrowsky, BE, Richet, HM, Jarvis, WR, Farr, BM. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 2003;24:362–386.Google Scholar
4.Fridkin, SK, Steward, CD, Edwards, JR, et al. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. Clin Infect Dis 1999;29:245–252.Google Scholar
5.Calfee, DP, Farr, BM. Use of active surveillance cultures to control vancomycin-resistant Enterococcus: reply. Clin Infect Dis 2003;37:1402–1403.Google Scholar